Medication info
Rozette Tablets (Losartan Potassium)

Rozette Tablets (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200607653 · Notified 2006.10.26

Summary

Main use
Treatment of hypertension and hypertensive nephropathy in patients with type 2 diabetes
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended to take it at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg losartan potassium orally once daily. The maximum blood pressure-lowering effect appears 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or the dose may be increased to 100 mg once daily if necessary. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with other antihypertensive medicines (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose of this medicine is 50 mg once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin or commonly used blood glucose-lowering medicines (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is required in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is required. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with decreased effective intravascular volume An initial dose of 25 mg of this medicine once daily is recommended for patients who may have decreased effective intravascular volume (e.g., patients receiving diuretics) (see Precautions for Use). 4) Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents 6 years and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and hypertensive nephropathy in patients with type 2 diabetes

  • Hypertension
  • kidney disease
View approved original text

This medication is used for managing hypertension. Additionally, it is effective in treating kidney disease in patients with type 2 diabetes who have hypertension. Therefore, it helps prevent associated renal complications as well as hypertension.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended to take it at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg losartan potassium orally once daily. The maximum blood pressure-lowering effect appears 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or the dose may be increased to 100 mg once daily if necessary. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with other antihypertensive medicines (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose of this medicine is 50 mg once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin or commonly used blood glucose-lowering medicines (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is required in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is required. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with decreased effective intravascular volume An initial dose of 25 mg of this medicine once daily is recommended for patients who may have decreased effective intravascular volume (e.g., patients receiving diuretics) (see Precautions for Use). 4) Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents 6 years and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication should not be taken by women who are pregnant or may become pregnant, especially during the second and third trimesters, as it can cause serious harm to the fetus. Patients with severely impaired liver function, a history of angioedema, or certain genetic disorders should not take this medication. Particular caution is required when used by elderly patients or those with impaired kidney function, or hyperkalemia; regular monitoring of blood pressure and blood tests is necessary. During treatment, dizziness or symptoms of hypotension may occur, so caution is advised when driving or operating machinery. Taking this medication together with potassium-sparing diuretics or potassium supplements may lead to dangerously high potassium levels; do not take any potassium-containing medication or supplements without consulting a doctor. Occasionally, side effects such as angioedema, allergic reactions, liver function abnormalities, muscle pain, and dry cough may occur, and any abnormal symptoms should be reported to medical personnel immediately. This medication may affect kidney function, so patients with kidney disease or heart failure require dose adjustments and monitoring under a doctor’s supervision. Regular monitoring of blood pressure, kidney function, and electrolyte levels is needed during treatment to check for abnormalities. Overdose may lead to symptoms such as hypotension and bradycardia, so it's essential to strictly adhere to the prescribed dosage, and if side effects occur, immediate medical attention is required. It is advisable to avoid grapefruit juice while taking this medication, and when using other medications, consult your doctor regarding potential interactions.

Side effects

  • Decreased skull formation
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • lumbago
  • leg pain
  • dizziness
  • congestion
Show 135 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • abdominal distension
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm desquamation
  • hemolytic phenomena
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree AV block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • myotonia
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorders
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • decreased libido
  • memory impairment
  • migraine
  • neuroexcitability
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorders
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • thoracic discomfort
  • hair loss
  • dermatitis
  • skin dryness
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • decreased vision
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urethral infection
  • angioedema
  • vasculitis
  • anaphylaxis-like syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • malaise
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased BUN
  • increased serum creatinine
  • decreased hemoglobin
  • decreased hematocrit
  • elevated liver enzymes
  • increased serum bilirubin
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular extrasystole
  • atrial fibrillation
  • hypoglycemia
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; it should be stored in a tightly sealed container. Additionally, it is important to maintain a temperature between 1°C and 30°C when storing the medication to ensure its effectiveness.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.